nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—Teniposide—lung cancer	0.292	0.627	CrCtD
Podofilox—Etoposide—lung cancer	0.174	0.373	CrCtD
Podofilox—Etoposide—Teniposide—lung cancer	0.171	0.627	CrCrCtD
Podofilox—Teniposide—Etoposide—lung cancer	0.101	0.373	CrCrCtD
Podofilox—TUBB—Vinorelbine—lung cancer	0.0435	0.215	CbGbCtD
Podofilox—TUBB—Paclitaxel—lung cancer	0.0305	0.151	CbGbCtD
Podofilox—TOP2A—Teniposide—lung cancer	0.0291	0.144	CbGbCtD
Podofilox—TUBB—Vinblastine—lung cancer	0.0268	0.133	CbGbCtD
Podofilox—TUBB—Docetaxel—lung cancer	0.0221	0.109	CbGbCtD
Podofilox—TOP2A—Etoposide—lung cancer	0.0128	0.0636	CbGbCtD
Podofilox—TOP2A—Doxorubicin—lung cancer	0.00876	0.0434	CbGbCtD
Podofilox—CYP2C19—Gefitinib—lung cancer	0.00498	0.0247	CbGbCtD
Podofilox—CYP2C19—Teniposide—lung cancer	0.00483	0.0239	CbGbCtD
Podofilox—CYP3A4—Topotecan—lung cancer	0.00263	0.013	CbGbCtD
Podofilox—CYP3A4—Gefitinib—lung cancer	0.00241	0.0119	CbGbCtD
Podofilox—CYP3A4—Teniposide—lung cancer	0.00233	0.0116	CbGbCtD
Podofilox—CYP3A4—Vinorelbine—lung cancer	0.00185	0.00918	CbGbCtD
Podofilox—CYP3A4—Crizotinib—lung cancer	0.00148	0.00731	CbGbCtD
Podofilox—CYP3A4—Erlotinib—lung cancer	0.00142	0.00705	CbGbCtD
Podofilox—CYP3A4—Paclitaxel—lung cancer	0.0013	0.00645	CbGbCtD
Podofilox—CYP3A4—Irinotecan—lung cancer	0.00128	0.00636	CbGbCtD
Podofilox—CYP3A4—Vinblastine—lung cancer	0.00114	0.00566	CbGbCtD
Podofilox—CYP3A4—Etoposide—lung cancer	0.00103	0.0051	CbGbCtD
Podofilox—TUBA4A—mammary gland—lung cancer	0.000966	0.112	CbGeAlD
Podofilox—CYP3A4—Docetaxel—lung cancer	0.000942	0.00466	CbGbCtD
Podofilox—Teniposide—NCOA3—lung cancer	0.000831	0.374	CrCbGaD
Podofilox—CYP3A4—Doxorubicin—lung cancer	0.000702	0.00348	CbGbCtD
Podofilox—TUBA4A—respiratory system—lung cancer	0.000644	0.0746	CbGeAlD
Podofilox—TUBA4A—epithelium—lung cancer	0.000538	0.0623	CbGeAlD
Podofilox—TUBA4A—bronchus—lung cancer	0.00053	0.0614	CbGeAlD
Podofilox—TUBA4A—trachea—lung cancer	0.000476	0.0551	CbGeAlD
Podofilox—TUBA4A—cardiac atrium—lung cancer	0.000447	0.0518	CbGeAlD
Podofilox—TOP2A—bronchus—lung cancer	0.000392	0.0454	CbGeAlD
Podofilox—TUBB—bronchus—lung cancer	0.000388	0.045	CbGeAlD
Podofilox—TUBA4A—bone marrow—lung cancer	0.000377	0.0437	CbGeAlD
Podofilox—TUBB—trachea—lung cancer	0.000349	0.0404	CbGeAlD
Podofilox—TUBA4A—lung—lung cancer	0.000342	0.0396	CbGeAlD
Podofilox—TUBB—cardiac atrium—lung cancer	0.000328	0.0379	CbGeAlD
Podofilox—Blister—Vinorelbine—lung cancer	0.000312	0.012	CcSEcCtD
Podofilox—Tenderness—Erlotinib—lung cancer	0.000298	0.0114	CcSEcCtD
Podofilox—Dry skin—Gefitinib—lung cancer	0.00029	0.0111	CcSEcCtD
Podofilox—TOP2A—bone marrow—lung cancer	0.000279	0.0323	CbGeAlD
Podofilox—TUBB—bone marrow—lung cancer	0.000277	0.032	CbGeAlD
Podofilox—Inflammation—Erlotinib—lung cancer	0.000268	0.0103	CcSEcCtD
Podofilox—TUBA4A—Afatinib—Gefitinib—lung cancer	0.000266	0.181	CbGdCrCtD
Podofilox—TUBA4A—Gefitinib—Erlotinib—lung cancer	0.000261	0.178	CbGdCrCtD
Podofilox—TOP2A—lung—lung cancer	0.000253	0.0293	CbGeAlD
Podofilox—Etoposide—ABCC3—lung cancer	0.000252	0.113	CrCbGaD
Podofilox—TUBB—lung—lung cancer	0.000251	0.029	CbGeAlD
Podofilox—Skin exfoliation—Erlotinib—lung cancer	0.000249	0.00952	CcSEcCtD
Podofilox—Etoposide—GSTT1—lung cancer	0.00024	0.108	CrCbGaD
Podofilox—TUBA4A—lymph node—lung cancer	0.000234	0.0271	CbGeAlD
Podofilox—Haematuria—Gefitinib—lung cancer	0.000232	0.0089	CcSEcCtD
Podofilox—Redness—Paclitaxel—lung cancer	0.000224	0.00859	CcSEcCtD
Podofilox—Haemoglobin—Gefitinib—lung cancer	0.00022	0.00842	CcSEcCtD
Podofilox—Haemorrhage—Gefitinib—lung cancer	0.000219	0.00838	CcSEcCtD
Podofilox—NR3C1—respiratory system—lung cancer	0.000219	0.0253	CbGeAlD
Podofilox—Etoposide—UGT1A1—lung cancer	0.000218	0.0978	CrCbGaD
Podofilox—Skin exfoliation—Vinorelbine—lung cancer	0.000215	0.00823	CcSEcCtD
Podofilox—Tenderness—Gemcitabine—lung cancer	0.000207	0.00794	CcSEcCtD
Podofilox—Dermatitis bullous—Topotecan—lung cancer	0.0002	0.00765	CcSEcCtD
Podofilox—Dermatitis bullous—Erlotinib—lung cancer	0.000198	0.00757	CcSEcCtD
Podofilox—Ulcer—Irinotecan—lung cancer	0.000196	0.00752	CcSEcCtD
Podofilox—Skin ulcer—Paclitaxel—lung cancer	0.000194	0.00745	CcSEcCtD
Podofilox—Tenderness—Cisplatin—lung cancer	0.000193	0.0074	CcSEcCtD
Podofilox—Tingling sensation—Etoposide—lung cancer	0.000192	0.00736	CcSEcCtD
Podofilox—Erythema—Pemetrexed—lung cancer	0.000192	0.00734	CcSEcCtD
Podofilox—Ulcer—Gemcitabine—lung cancer	0.000191	0.00732	CcSEcCtD
Podofilox—Redness—Docetaxel—lung cancer	0.00019	0.00728	CcSEcCtD
Podofilox—Etoposide—GSTP1—lung cancer	0.000189	0.0851	CrCbGaD
Podofilox—Tingling sensation—Paclitaxel—lung cancer	0.000188	0.00721	CcSEcCtD
Podofilox—NR3C1—epithelium—lung cancer	0.000183	0.0212	CbGeAlD
Podofilox—NR3C1—bronchus—lung cancer	0.00018	0.0208	CbGeAlD
Podofilox—Haemoglobin—Teniposide—lung cancer	0.000179	0.00686	CcSEcCtD
Podofilox—Haemorrhage—Teniposide—lung cancer	0.000178	0.00683	CcSEcCtD
Podofilox—Ulcer—Cisplatin—lung cancer	0.000178	0.00683	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Crizotinib—lung cancer	0.000177	0.00679	CcSEcCtD
Podofilox—Tenderness—Paclitaxel—lung cancer	0.000174	0.00665	CcSEcCtD
Podofilox—Dry skin—Erlotinib—lung cancer	0.000173	0.00663	CcSEcCtD
Podofilox—TOP2A—lymph node—lung cancer	0.000173	0.02	CbGeAlD
Podofilox—Skin exfoliation—Gemcitabine—lung cancer	0.000173	0.00661	CcSEcCtD
Podofilox—TUBB—lymph node—lung cancer	0.000171	0.0199	CbGeAlD
Podofilox—Oedema—Crizotinib—lung cancer	0.000171	0.00655	CcSEcCtD
Podofilox—Dermatitis bullous—Vinorelbine—lung cancer	0.000171	0.00655	CcSEcCtD
Podofilox—Skin discolouration—Etoposide—lung cancer	0.000171	0.00655	CcSEcCtD
Podofilox—Skin discolouration—Paclitaxel—lung cancer	0.000168	0.00642	CcSEcCtD
Podofilox—Skin disorder—Crizotinib—lung cancer	0.000166	0.00637	CcSEcCtD
Podofilox—Teniposide—ABCG2—lung cancer	0.000165	0.0741	CrCbGaD
Podofilox—Ulcer—Etoposide—lung cancer	0.000163	0.00625	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Pemetrexed—lung cancer	0.000162	0.0062	CcSEcCtD
Podofilox—NR3C1—trachea—lung cancer	0.000162	0.0187	CbGeAlD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Gefitinib—lung cancer	0.000161	0.00617	CcSEcCtD
Podofilox—Skin exfoliation—Cisplatin—lung cancer	0.000161	0.00616	CcSEcCtD
Podofilox—Inflammation—Etoposide—lung cancer	0.000159	0.0061	CcSEcCtD
Podofilox—Oedema—Pemetrexed—lung cancer	0.000156	0.00599	CcSEcCtD
Podofilox—Paraesthesia—Crizotinib—lung cancer	0.000154	0.00588	CcSEcCtD
Podofilox—Skin disorder—Pemetrexed—lung cancer	0.000152	0.00582	CcSEcCtD
Podofilox—NR3C1—cardiac atrium—lung cancer	0.000152	0.0176	CbGeAlD
Podofilox—Skin disorder—Gefitinib—lung cancer	0.000151	0.00578	CcSEcCtD
Podofilox—Skin exfoliation—Etoposide—lung cancer	0.000147	0.00565	CcSEcCtD
Podofilox—Skin exfoliation—Paclitaxel—lung cancer	0.000145	0.00554	CcSEcCtD
Podofilox—Dermatitis bullous—Gemcitabine—lung cancer	0.000137	0.00526	CcSEcCtD
Podofilox—Haemoglobin—Vinblastine—lung cancer	0.000137	0.00524	CcSEcCtD
Podofilox—Haemorrhage—Vinblastine—lung cancer	0.000136	0.00521	CcSEcCtD
Podofilox—Pain—Pemetrexed—lung cancer	0.000134	0.00512	CcSEcCtD
Podofilox—Pain—Gefitinib—lung cancer	0.000133	0.00509	CcSEcCtD
Podofilox—Haemoglobin—Topotecan—lung cancer	0.000133	0.00509	CcSEcCtD
Podofilox—Inflammation—Docetaxel—lung cancer	0.000132	0.00507	CcSEcCtD
Podofilox—Haemorrhage—Topotecan—lung cancer	0.000132	0.00506	CcSEcCtD
Podofilox—Haemoglobin—Erlotinib—lung cancer	0.000131	0.00503	CcSEcCtD
Podofilox—Haemorrhage—Erlotinib—lung cancer	0.000131	0.00501	CcSEcCtD
Podofilox—NR3C1—bone marrow—lung cancer	0.000128	0.0148	CbGeAlD
Podofilox—Swelling—Etoposide—lung cancer	0.000127	0.00487	CcSEcCtD
Podofilox—Oedema—Teniposide—lung cancer	0.000127	0.00485	CcSEcCtD
Podofilox—Swelling—Paclitaxel—lung cancer	0.000125	0.00477	CcSEcCtD
Podofilox—Skin exfoliation—Docetaxel—lung cancer	0.000123	0.00469	CcSEcCtD
Podofilox—Etoposide—ABCG2—lung cancer	0.000122	0.055	CrCbGaD
Podofilox—Immune system disorder—Topotecan—lung cancer	0.000119	0.00457	CcSEcCtD
Podofilox—Skin ulcer—Methotrexate—lung cancer	0.000119	0.00455	CcSEcCtD
Podofilox—Redness—Doxorubicin—lung cancer	0.000119	0.00454	CcSEcCtD
Podofilox—NR3C1—lung—lung cancer	0.000116	0.0134	CbGeAlD
Podofilox—Erythema—Erlotinib—lung cancer	0.000114	0.00436	CcSEcCtD
Podofilox—Dizziness—Crizotinib—lung cancer	0.000113	0.00433	CcSEcCtD
Podofilox—Blister—Doxorubicin—lung cancer	0.000111	0.00426	CcSEcCtD
Podofilox—Pruritus—Pemetrexed—lung cancer	0.000111	0.00424	CcSEcCtD
Podofilox—Pruritus—Gefitinib—lung cancer	0.00011	0.00421	CcSEcCtD
Podofilox—Vomiting—Crizotinib—lung cancer	0.000109	0.00417	CcSEcCtD
Podofilox—Rash—Crizotinib—lung cancer	0.000108	0.00413	CcSEcCtD
Podofilox—Dermatitis—Crizotinib—lung cancer	0.000108	0.00413	CcSEcCtD
Podofilox—Swelling—Docetaxel—lung cancer	0.000106	0.00404	CcSEcCtD
Podofilox—Dizziness—Pemetrexed—lung cancer	0.000103	0.00396	CcSEcCtD
Podofilox—Skin ulcer—Doxorubicin—lung cancer	0.000103	0.00394	CcSEcCtD
Podofilox—Skin discolouration—Methotrexate—lung cancer	0.000102	0.00392	CcSEcCtD
Podofilox—Immune system disorder—Vinorelbine—lung cancer	0.000102	0.00391	CcSEcCtD
Podofilox—Dry skin—Paclitaxel—lung cancer	0.000101	0.00386	CcSEcCtD
Podofilox—Vomiting—Pemetrexed—lung cancer	9.94e-05	0.00381	CcSEcCtD
Podofilox—Stinging—Doxorubicin—lung cancer	9.88e-05	0.00379	CcSEcCtD
Podofilox—Vomiting—Gefitinib—lung cancer	9.88e-05	0.00378	CcSEcCtD
Podofilox—Rash—Pemetrexed—lung cancer	9.86e-05	0.00378	CcSEcCtD
Podofilox—Dermatitis—Pemetrexed—lung cancer	9.85e-05	0.00377	CcSEcCtD
Podofilox—Erythema—Vinorelbine—lung cancer	9.84e-05	0.00377	CcSEcCtD
Podofilox—Rash—Gefitinib—lung cancer	9.8e-05	0.00375	CcSEcCtD
Podofilox—Dermatitis—Gefitinib—lung cancer	9.79e-05	0.00375	CcSEcCtD
Podofilox—Ulcer—Methotrexate—lung cancer	9.78e-05	0.00375	CcSEcCtD
Podofilox—Dermatitis bullous—Docetaxel—lung cancer	9.75e-05	0.00373	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Topotecan—lung cancer	9.72e-05	0.00373	CcSEcCtD
Podofilox—Etoposide—CYP2E1—lung cancer	9.71e-05	0.0437	CrCbGaD
Podofilox—Haematuria—Gemcitabine—lung cancer	9.64e-05	0.00369	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—lung cancer	9.62e-05	0.00369	CcSEcCtD
Podofilox—Inflammation—Methotrexate—lung cancer	9.53e-05	0.00365	CcSEcCtD
Podofilox—TOP2A—Docetaxel—Paclitaxel—lung cancer	9.46e-05	0.0645	CbGdCrCtD
Podofilox—Haemoglobin—Irinotecan—lung cancer	9.37e-05	0.00359	CcSEcCtD
Podofilox—Haemorrhage—Irinotecan—lung cancer	9.32e-05	0.00357	CcSEcCtD
Podofilox—Oedema—Erlotinib—lung cancer	9.29e-05	0.00356	CcSEcCtD
Podofilox—Haemoglobin—Gemcitabine—lung cancer	9.13e-05	0.0035	CcSEcCtD
Podofilox—Skin disorder—Topotecan—lung cancer	9.12e-05	0.00349	CcSEcCtD
Podofilox—Haemorrhage—Gemcitabine—lung cancer	9.08e-05	0.00348	CcSEcCtD
Podofilox—Skin disorder—Erlotinib—lung cancer	9.02e-05	0.00346	CcSEcCtD
Podofilox—Pruritus—Teniposide—lung cancer	8.96e-05	0.00343	CcSEcCtD
Podofilox—Skin discolouration—Doxorubicin—lung cancer	8.87e-05	0.0034	CcSEcCtD
Podofilox—Skin exfoliation—Methotrexate—lung cancer	8.83e-05	0.00338	CcSEcCtD
Podofilox—Paraesthesia—Vinblastine—lung cancer	8.68e-05	0.00332	CcSEcCtD
Podofilox—Dry skin—Docetaxel—lung cancer	8.54e-05	0.00327	CcSEcCtD
Podofilox—Ulcer—Doxorubicin—lung cancer	8.47e-05	0.00324	CcSEcCtD
Podofilox—Paraesthesia—Topotecan—lung cancer	8.43e-05	0.00323	CcSEcCtD
Podofilox—Immune system disorder—Irinotecan—lung cancer	8.42e-05	0.00323	CcSEcCtD
Podofilox—Insomnia—Erlotinib—lung cancer	8.4e-05	0.00322	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—lung cancer	8.32e-05	0.00319	CcSEcCtD
Podofilox—Pain—Vinblastine—lung cancer	8.26e-05	0.00317	CcSEcCtD
Podofilox—Inflammation—Doxorubicin—lung cancer	8.26e-05	0.00316	CcSEcCtD
Podofilox—Immune system disorder—Gemcitabine—lung cancer	8.2e-05	0.00314	CcSEcCtD
Podofilox—TOP2A—Irinotecan—Topotecan—lung cancer	8.1e-05	0.0552	CbGdCrCtD
Podofilox—Haematuria—Paclitaxel—lung cancer	8.07e-05	0.00309	CcSEcCtD
Podofilox—Vomiting—Teniposide—lung cancer	8.05e-05	0.00308	CcSEcCtD
Podofilox—Pain—Topotecan—lung cancer	8.03e-05	0.00307	CcSEcCtD
Podofilox—Rash—Teniposide—lung cancer	7.99e-05	0.00306	CcSEcCtD
Podofilox—Dermatitis—Teniposide—lung cancer	7.98e-05	0.00306	CcSEcCtD
Podofilox—Pain—Erlotinib—lung cancer	7.94e-05	0.00304	CcSEcCtD
Podofilox—NR3C1—lymph node—lung cancer	7.94e-05	0.0092	CbGeAlD
Podofilox—Headache—Teniposide—lung cancer	7.93e-05	0.00304	CcSEcCtD
Podofilox—Erythema—Gemcitabine—lung cancer	7.9e-05	0.00303	CcSEcCtD
Podofilox—Skin disorder—Vinorelbine—lung cancer	7.8e-05	0.00299	CcSEcCtD
Podofilox—Skin exfoliation—Doxorubicin—lung cancer	7.65e-05	0.00293	CcSEcCtD
Podofilox—Immune system disorder—Cisplatin—lung cancer	7.64e-05	0.00293	CcSEcCtD
Podofilox—Haemoglobin—Paclitaxel—lung cancer	7.64e-05	0.00293	CcSEcCtD
Podofilox—Haemorrhage—Paclitaxel—lung cancer	7.6e-05	0.00291	CcSEcCtD
Podofilox—Erythema—Cisplatin—lung cancer	7.37e-05	0.00282	CcSEcCtD
Podofilox—Paraesthesia—Vinorelbine—lung cancer	7.21e-05	0.00276	CcSEcCtD
Podofilox—TOP2A—Erlotinib—Gefitinib—lung cancer	7.07e-05	0.0482	CbGdCrCtD
Podofilox—Immune system disorder—Etoposide—lung cancer	7e-05	0.00268	CcSEcCtD
Podofilox—Pain—Vinorelbine—lung cancer	6.87e-05	0.00263	CcSEcCtD
Podofilox—Immune system disorder—Paclitaxel—lung cancer	6.87e-05	0.00263	CcSEcCtD
Podofilox—TOP2A—Topotecan—Irinotecan—lung cancer	6.73e-05	0.0459	CbGdCrCtD
Podofilox—TOP2A—Etoposide—Teniposide—lung cancer	6.69e-05	0.0456	CbGdCrCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	6.68e-05	0.00256	CcSEcCtD
Podofilox—Pruritus—Topotecan—lung cancer	6.64e-05	0.00254	CcSEcCtD
Podofilox—Oedema—Irinotecan—lung cancer	6.62e-05	0.00254	CcSEcCtD
Podofilox—Erythema—Paclitaxel—lung cancer	6.62e-05	0.00254	CcSEcCtD
Podofilox—Pruritus—Erlotinib—lung cancer	6.57e-05	0.00252	CcSEcCtD
Podofilox—Haemoglobin—Docetaxel—lung cancer	6.48e-05	0.00248	CcSEcCtD
Podofilox—Oedema—Gemcitabine—lung cancer	6.45e-05	0.00247	CcSEcCtD
Podofilox—Haemorrhage—Docetaxel—lung cancer	6.44e-05	0.00247	CcSEcCtD
Podofilox—Dizziness—Vinblastine—lung cancer	6.39e-05	0.00245	CcSEcCtD
Podofilox—Skin disorder—Gemcitabine—lung cancer	6.27e-05	0.0024	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	6.23e-05	0.00239	CcSEcCtD
Podofilox—Dizziness—Topotecan—lung cancer	6.21e-05	0.00238	CcSEcCtD
Podofilox—Vomiting—Vinblastine—lung cancer	6.14e-05	0.00235	CcSEcCtD
Podofilox—Dizziness—Erlotinib—lung cancer	6.14e-05	0.00235	CcSEcCtD
Podofilox—Dermatitis bullous—Doxorubicin—lung cancer	6.08e-05	0.00233	CcSEcCtD
Podofilox—Headache—Vinblastine—lung cancer	6.05e-05	0.00232	CcSEcCtD
Podofilox—TOP2A—Vindesine—Vinorelbine—lung cancer	6.02e-05	0.041	CbGdCrCtD
Podofilox—Oedema—Cisplatin—lung cancer	6.01e-05	0.0023	CcSEcCtD
Podofilox—Insomnia—Irinotecan—lung cancer	5.99e-05	0.00229	CcSEcCtD
Podofilox—Etoposide—PTGS2—lung cancer	5.99e-05	0.0269	CrCbGaD
Podofilox—Vomiting—Topotecan—lung cancer	5.97e-05	0.00229	CcSEcCtD
Podofilox—Paraesthesia—Irinotecan—lung cancer	5.95e-05	0.00228	CcSEcCtD
Podofilox—Rash—Topotecan—lung cancer	5.92e-05	0.00227	CcSEcCtD
Podofilox—Dermatitis—Topotecan—lung cancer	5.91e-05	0.00227	CcSEcCtD
Podofilox—Vomiting—Erlotinib—lung cancer	5.91e-05	0.00226	CcSEcCtD
Podofilox—Headache—Topotecan—lung cancer	5.88e-05	0.00225	CcSEcCtD
Podofilox—Rash—Erlotinib—lung cancer	5.86e-05	0.00224	CcSEcCtD
Podofilox—Dermatitis—Erlotinib—lung cancer	5.85e-05	0.00224	CcSEcCtD
Podofilox—Skin disorder—Cisplatin—lung cancer	5.84e-05	0.00224	CcSEcCtD
Podofilox—Insomnia—Gemcitabine—lung cancer	5.83e-05	0.00224	CcSEcCtD
Podofilox—Immune system disorder—Docetaxel—lung cancer	5.82e-05	0.00223	CcSEcCtD
Podofilox—Headache—Erlotinib—lung cancer	5.82e-05	0.00223	CcSEcCtD
Podofilox—Paraesthesia—Gemcitabine—lung cancer	5.79e-05	0.00222	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	5.71e-05	0.00219	CcSEcCtD
Podofilox—Pruritus—Vinorelbine—lung cancer	5.68e-05	0.00218	CcSEcCtD
Podofilox—Pain—Irinotecan—lung cancer	5.66e-05	0.00217	CcSEcCtD
Podofilox—Erythema—Docetaxel—lung cancer	5.61e-05	0.00215	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	5.6e-05	0.00214	CcSEcCtD
Podofilox—Pain—Gemcitabine—lung cancer	5.52e-05	0.00211	CcSEcCtD
Podofilox—Oedema—Paclitaxel—lung cancer	5.4e-05	0.00207	CcSEcCtD
Podofilox—Paraesthesia—Cisplatin—lung cancer	5.4e-05	0.00207	CcSEcCtD
Podofilox—Skin disorder—Etoposide—lung cancer	5.35e-05	0.00205	CcSEcCtD
Podofilox—Dry skin—Doxorubicin—lung cancer	5.33e-05	0.00204	CcSEcCtD
Podofilox—Dizziness—Vinorelbine—lung cancer	5.31e-05	0.00203	CcSEcCtD
Podofilox—Skin disorder—Paclitaxel—lung cancer	5.25e-05	0.00201	CcSEcCtD
Podofilox—Pain—Cisplatin—lung cancer	5.14e-05	0.00197	CcSEcCtD
Podofilox—Vomiting—Vinorelbine—lung cancer	5.11e-05	0.00196	CcSEcCtD
Podofilox—Etoposide—ABCB1—lung cancer	5.09e-05	0.0229	CrCbGaD
Podofilox—Rash—Vinorelbine—lung cancer	5.06e-05	0.00194	CcSEcCtD
Podofilox—Dermatitis—Vinorelbine—lung cancer	5.06e-05	0.00194	CcSEcCtD
Podofilox—Headache—Vinorelbine—lung cancer	5.03e-05	0.00193	CcSEcCtD
Podofilox—Paraesthesia—Etoposide—lung cancer	4.95e-05	0.00189	CcSEcCtD
Podofilox—Haematuria—Methotrexate—lung cancer	4.93e-05	0.00189	CcSEcCtD
Podofilox—Insomnia—Paclitaxel—lung cancer	4.89e-05	0.00187	CcSEcCtD
Podofilox—Paraesthesia—Paclitaxel—lung cancer	4.85e-05	0.00186	CcSEcCtD
Podofilox—TOP2A—Vindesine—Vinblastine—lung cancer	4.81e-05	0.0328	CbGdCrCtD
Podofilox—TOP2A—Methotrexate—Pemetrexed—lung cancer	4.8e-05	0.0327	CbGdCrCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	4.74e-05	0.00182	CcSEcCtD
Podofilox—TOP2A—Paclitaxel—Docetaxel—lung cancer	4.72e-05	0.0322	CbGdCrCtD
Podofilox—Pain—Etoposide—lung cancer	4.71e-05	0.0018	CcSEcCtD
Podofilox—TUBB—Azacitidine—Gemcitabine—lung cancer	4.68e-05	0.0319	CbGdCrCtD
Podofilox—Haemoglobin—Methotrexate—lung cancer	4.67e-05	0.00179	CcSEcCtD
Podofilox—Haemorrhage—Methotrexate—lung cancer	4.64e-05	0.00178	CcSEcCtD
Podofilox—TOP2A—Afatinib—Gefitinib—lung cancer	4.62e-05	0.0315	CbGdCrCtD
Podofilox—Pain—Paclitaxel—lung cancer	4.62e-05	0.00177	CcSEcCtD
Podofilox—Oedema—Docetaxel—lung cancer	4.58e-05	0.00175	CcSEcCtD
Podofilox—Pruritus—Gemcitabine—lung cancer	4.56e-05	0.00175	CcSEcCtD
Podofilox—TOP2A—Gefitinib—Erlotinib—lung cancer	4.53e-05	0.0309	CbGdCrCtD
Podofilox—Skin disorder—Docetaxel—lung cancer	4.45e-05	0.0017	CcSEcCtD
Podofilox—Dizziness—Irinotecan—lung cancer	4.38e-05	0.00168	CcSEcCtD
Podofilox—Haematuria—Doxorubicin—lung cancer	4.27e-05	0.00164	CcSEcCtD
Podofilox—Vomiting—Irinotecan—lung cancer	4.21e-05	0.00161	CcSEcCtD
Podofilox—Immune system disorder—Methotrexate—lung cancer	4.19e-05	0.00161	CcSEcCtD
Podofilox—Rash—Irinotecan—lung cancer	4.18e-05	0.0016	CcSEcCtD
Podofilox—Dermatitis—Irinotecan—lung cancer	4.17e-05	0.0016	CcSEcCtD
Podofilox—Headache—Irinotecan—lung cancer	4.15e-05	0.00159	CcSEcCtD
Podofilox—Insomnia—Docetaxel—lung cancer	4.14e-05	0.00159	CcSEcCtD
Podofilox—Paraesthesia—Docetaxel—lung cancer	4.11e-05	0.00157	CcSEcCtD
Podofilox—Vomiting—Gemcitabine—lung cancer	4.1e-05	0.00157	CcSEcCtD
Podofilox—Rash—Gemcitabine—lung cancer	4.07e-05	0.00156	CcSEcCtD
Podofilox—Dermatitis—Gemcitabine—lung cancer	4.06e-05	0.00156	CcSEcCtD
Podofilox—Erythema—Methotrexate—lung cancer	4.04e-05	0.00155	CcSEcCtD
Podofilox—Haemoglobin—Doxorubicin—lung cancer	4.04e-05	0.00155	CcSEcCtD
Podofilox—Headache—Gemcitabine—lung cancer	4.04e-05	0.00155	CcSEcCtD
Podofilox—Haemorrhage—Doxorubicin—lung cancer	4.02e-05	0.00154	CcSEcCtD
Podofilox—Pain—Docetaxel—lung cancer	3.91e-05	0.0015	CcSEcCtD
Podofilox—Pruritus—Etoposide—lung cancer	3.9e-05	0.00149	CcSEcCtD
Podofilox—Vomiting—Cisplatin—lung cancer	3.82e-05	0.00146	CcSEcCtD
Podofilox—Pruritus—Paclitaxel—lung cancer	3.82e-05	0.00146	CcSEcCtD
Podofilox—Rash—Cisplatin—lung cancer	3.79e-05	0.00145	CcSEcCtD
Podofilox—Dermatitis—Cisplatin—lung cancer	3.79e-05	0.00145	CcSEcCtD
Podofilox—Dizziness—Etoposide—lung cancer	3.64e-05	0.0014	CcSEcCtD
Podofilox—Immune system disorder—Doxorubicin—lung cancer	3.63e-05	0.00139	CcSEcCtD
Podofilox—Dizziness—Paclitaxel—lung cancer	3.57e-05	0.00137	CcSEcCtD
Podofilox—Vomiting—Etoposide—lung cancer	3.5e-05	0.00134	CcSEcCtD
Podofilox—Erythema—Doxorubicin—lung cancer	3.5e-05	0.00134	CcSEcCtD
Podofilox—Rash—Etoposide—lung cancer	3.47e-05	0.00133	CcSEcCtD
Podofilox—Dermatitis—Etoposide—lung cancer	3.47e-05	0.00133	CcSEcCtD
Podofilox—Headache—Etoposide—lung cancer	3.45e-05	0.00132	CcSEcCtD
Podofilox—Vomiting—Paclitaxel—lung cancer	3.43e-05	0.00132	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	3.42e-05	0.00131	CcSEcCtD
Podofilox—Rash—Paclitaxel—lung cancer	3.41e-05	0.0013	CcSEcCtD
Podofilox—Dermatitis—Paclitaxel—lung cancer	3.4e-05	0.0013	CcSEcCtD
Podofilox—Headache—Paclitaxel—lung cancer	3.38e-05	0.0013	CcSEcCtD
Podofilox—TOP2A—Vincristine—Vinorelbine—lung cancer	3.25e-05	0.0221	CbGdCrCtD
Podofilox—Pruritus—Docetaxel—lung cancer	3.24e-05	0.00124	CcSEcCtD
Podofilox—Skin disorder—Methotrexate—lung cancer	3.21e-05	0.00123	CcSEcCtD
Podofilox—TOP2A—Vinorelbine—Vinblastine—lung cancer	3.04e-05	0.0207	CbGdCrCtD
Podofilox—TOP2A—Teniposide—Etoposide—lung cancer	3.03e-05	0.0207	CbGdCrCtD
Podofilox—Dizziness—Docetaxel—lung cancer	3.03e-05	0.00116	CcSEcCtD
Podofilox—Insomnia—Methotrexate—lung cancer	2.98e-05	0.00114	CcSEcCtD
Podofilox—Paraesthesia—Methotrexate—lung cancer	2.96e-05	0.00113	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.96e-05	0.00113	CcSEcCtD
Podofilox—Vomiting—Docetaxel—lung cancer	2.91e-05	0.00111	CcSEcCtD
Podofilox—Rash—Docetaxel—lung cancer	2.89e-05	0.00111	CcSEcCtD
Podofilox—Dermatitis—Docetaxel—lung cancer	2.88e-05	0.0011	CcSEcCtD
Podofilox—Headache—Docetaxel—lung cancer	2.87e-05	0.0011	CcSEcCtD
Podofilox—Oedema—Doxorubicin—lung cancer	2.86e-05	0.00109	CcSEcCtD
Podofilox—Pain—Methotrexate—lung cancer	2.82e-05	0.00108	CcSEcCtD
Podofilox—Skin disorder—Doxorubicin—lung cancer	2.78e-05	0.00106	CcSEcCtD
Podofilox—TOP2A—Vinblastine—Vinorelbine—lung cancer	2.61e-05	0.0178	CbGdCrCtD
Podofilox—TOP2A—Vincristine—Vinblastine—lung cancer	2.6e-05	0.0177	CbGdCrCtD
Podofilox—Insomnia—Doxorubicin—lung cancer	2.58e-05	0.00099	CcSEcCtD
Podofilox—Paraesthesia—Doxorubicin—lung cancer	2.57e-05	0.000983	CcSEcCtD
Podofilox—Pain—Doxorubicin—lung cancer	2.44e-05	0.000936	CcSEcCtD
Podofilox—Pruritus—Methotrexate—lung cancer	2.33e-05	0.000894	CcSEcCtD
Podofilox—Dizziness—Methotrexate—lung cancer	2.18e-05	0.000836	CcSEcCtD
Podofilox—Vomiting—Methotrexate—lung cancer	2.1e-05	0.000804	CcSEcCtD
Podofilox—Rash—Methotrexate—lung cancer	2.08e-05	0.000797	CcSEcCtD
Podofilox—Dermatitis—Methotrexate—lung cancer	2.08e-05	0.000796	CcSEcCtD
Podofilox—Headache—Methotrexate—lung cancer	2.07e-05	0.000792	CcSEcCtD
Podofilox—Pruritus—Doxorubicin—lung cancer	2.02e-05	0.000774	CcSEcCtD
Podofilox—Dizziness—Doxorubicin—lung cancer	1.89e-05	0.000724	CcSEcCtD
Podofilox—Vomiting—Doxorubicin—lung cancer	1.82e-05	0.000696	CcSEcCtD
Podofilox—Rash—Doxorubicin—lung cancer	1.8e-05	0.00069	CcSEcCtD
Podofilox—Dermatitis—Doxorubicin—lung cancer	1.8e-05	0.000689	CcSEcCtD
Podofilox—Headache—Doxorubicin—lung cancer	1.79e-05	0.000686	CcSEcCtD
Podofilox—TOP2A—Cytarabine—Gemcitabine—lung cancer	1.71e-05	0.0116	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Doxorubicin—lung cancer	1.46e-05	0.00998	CbGdCrCtD
Podofilox—TOP2A—Idarubicin—Doxorubicin—lung cancer	1.46e-05	0.00998	CbGdCrCtD
Podofilox—TOP2A—Epirubicin—Doxorubicin—lung cancer	1.46e-05	0.00998	CbGdCrCtD
Podofilox—TUBB—Cell Cycle—RB1—lung cancer	1.23e-05	0.000569	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—AKT1—lung cancer	1.23e-05	0.000569	CbGpPWpGaD
Podofilox—TOP2A—Azacitidine—Gemcitabine—lung cancer	1.22e-05	0.00834	CbGdCrCtD
Podofilox—NR3C1—AP-1 transcription factor network—IL6—lung cancer	1.22e-05	0.000564	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.22e-05	0.000564	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—UGT1A1—lung cancer	1.22e-05	0.000563	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN2A—lung cancer	1.21e-05	0.00056	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NOTCH3—lung cancer	1.21e-05	0.000559	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CCND1—lung cancer	1.2e-05	0.000556	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	1.2e-05	0.000556	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—CDKN1A—lung cancer	1.19e-05	0.000551	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.18e-05	0.000548	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	1.17e-05	0.000543	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TP53—lung cancer	1.17e-05	0.000543	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IL2—lung cancer	1.17e-05	0.000541	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN1A—lung cancer	1.16e-05	0.000538	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.16e-05	0.000536	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTP1—lung cancer	1.16e-05	0.000536	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—MMP2—lung cancer	1.16e-05	0.000536	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—JUNB—lung cancer	1.14e-05	0.000529	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CXCL8—lung cancer	1.14e-05	0.000529	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—BIRC5—lung cancer	1.14e-05	0.000528	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTP1—lung cancer	1.14e-05	0.000528	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	1.14e-05	0.000528	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—DICER1—lung cancer	1.13e-05	0.000525	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—EP300—lung cancer	1.11e-05	0.000512	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TERT—lung cancer	1.11e-05	0.000512	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.09e-05	0.000506	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CASP3—lung cancer	1.09e-05	0.000506	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN2A—lung cancer	1.08e-05	0.000501	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CCND1—lung cancer	1.07e-05	0.000497	CbGpPWpGaD
Podofilox—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	1.07e-05	0.000497	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL6—lung cancer	1.07e-05	0.000497	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTM1—lung cancer	1.06e-05	0.000492	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—STAT3—lung cancer	1.06e-05	0.000492	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—JUN—lung cancer	1.06e-05	0.000491	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	1.05e-05	0.000486	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MDM2—lung cancer	1.05e-05	0.000485	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTM1—lung cancer	1.05e-05	0.000485	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—EP300—lung cancer	1.05e-05	0.000485	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN1A—lung cancer	1.04e-05	0.000481	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—HPGDS—lung cancer	1.03e-05	0.000479	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CCND1—lung cancer	1.02e-05	0.000473	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—SRC—lung cancer	1.02e-05	0.000472	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP1A1—lung cancer	1.01e-05	0.000467	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1e-05	0.000465	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTT1—lung cancer	1e-05	0.000465	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	9.99e-06	0.000463	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP1A1—lung cancer	9.94e-06	0.00046	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—VEGFA—lung cancer	9.92e-06	0.000459	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP2A6—lung cancer	9.92e-06	0.000459	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GCLC—lung cancer	9.92e-06	0.000459	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MAPK3—lung cancer	9.91e-06	0.000459	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—AKT1—lung cancer	9.9e-06	0.000458	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—EP300—lung cancer	9.89e-06	0.000458	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN1A—lung cancer	9.88e-06	0.000458	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—NRAS—lung cancer	9.8e-06	0.000454	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SKI—lung cancer	9.79e-06	0.000453	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—EP300—lung cancer	9.79e-06	0.000453	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	9.72e-06	0.00045	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MYC—lung cancer	9.64e-06	0.000446	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—RB1—lung cancer	9.62e-06	0.000445	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CXCL8—lung cancer	9.61e-06	0.000445	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—EP300—lung cancer	9.4e-06	0.000435	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—MAPK3—lung cancer	9.39e-06	0.000435	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TP53—lung cancer	9.33e-06	0.000432	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—VEGFA—lung cancer	9.27e-06	0.000429	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CCND1—lung cancer	9.13e-06	0.000423	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—COL4A3BP—lung cancer	8.86e-06	0.00041	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AZIN2—lung cancer	8.86e-06	0.00041	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MAPK3—lung cancer	8.86e-06	0.00041	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN1A—lung cancer	8.84e-06	0.000409	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MYC—lung cancer	8.62e-06	0.000399	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—RB1—lung cancer	8.6e-06	0.000398	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—IL6—lung cancer	8.54e-06	0.000396	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	8.5e-06	0.000394	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN2A—lung cancer	8.46e-06	0.000392	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—KRAS—lung cancer	8.44e-06	0.000391	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP2E1—lung cancer	8.43e-06	0.00039	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MAPK3—lung cancer	8.42e-06	0.00039	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—EP300—lung cancer	8.41e-06	0.000389	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	8.32e-06	0.000385	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	8.26e-06	0.000383	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	8.21e-06	0.00038	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MYC—lung cancer	8.19e-06	0.000379	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	8e-06	0.000371	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—RARB—lung cancer	7.86e-06	0.000364	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CA—lung cancer	7.75e-06	0.000359	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NPPA—lung cancer	7.66e-06	0.000355	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN2A—lung cancer	7.56e-06	0.00035	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ATP5H—lung cancer	7.54e-06	0.000349	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MAPK3—lung cancer	7.53e-06	0.000349	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—POMC—lung cancer	7.51e-06	0.000348	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TP53—lung cancer	7.5e-06	0.000347	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—IL6—lung cancer	7.42e-06	0.000344	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MDM2—lung cancer	7.33e-06	0.00034	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MYC—lung cancer	7.33e-06	0.000339	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—HRAS—lung cancer	7.17e-06	0.000332	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CCND1—lung cancer	7.14e-06	0.000331	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—lung cancer	7.08e-06	0.000328	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTP1—lung cancer	6.96e-06	0.000322	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	6.93e-06	0.000321	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN1A—lung cancer	6.91e-06	0.00032	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	6.86e-06	0.000318	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PLBD1—lung cancer	6.72e-06	0.000311	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	6.61e-06	0.000306	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HSPB1—lung cancer	6.59e-06	0.000305	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—EP300—lung cancer	6.58e-06	0.000304	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL6—lung cancer	6.41e-06	0.000297	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTM1—lung cancer	6.39e-06	0.000296	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CCND1—lung cancer	6.39e-06	0.000296	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—AKT1—lung cancer	6.33e-06	0.000293	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	6.3e-06	0.000292	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN1A—lung cancer	6.18e-06	0.000286	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HSD17B10—lung cancer	6.14e-06	0.000284	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—CREBBP—lung cancer	6.07e-06	0.000281	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP1A1—lung cancer	6.06e-06	0.000281	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—lung cancer	6.02e-06	0.000279	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	5.98e-06	0.000277	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MAPK3—lung cancer	5.89e-06	0.000273	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—EP300—lung cancer	5.88e-06	0.000272	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NOTCH3—lung cancer	5.81e-06	0.000269	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MYC—lung cancer	5.73e-06	0.000265	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CKB—lung cancer	5.71e-06	0.000264	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—JUNB—lung cancer	5.5e-06	0.000255	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CNDP2—lung cancer	5.37e-06	0.000249	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTM2—lung cancer	5.37e-06	0.000249	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AZIN2—lung cancer	5.33e-06	0.000247	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—COL4A3BP—lung cancer	5.33e-06	0.000247	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MAPK3—lung cancer	5.27e-06	0.000244	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MTMR3—lung cancer	5.22e-06	0.000242	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MYC—lung cancer	5.12e-06	0.000237	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PGAM1—lung cancer	5.09e-06	0.000236	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP2A7—lung cancer	4.86e-06	0.000225	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SDC4—lung cancer	4.75e-06	0.00022	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ATP5H—lung cancer	4.53e-06	0.00021	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—POMC—lung cancer	4.52e-06	0.000209	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—RRM1—lung cancer	4.33e-06	0.0002	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTA3—lung cancer	4.33e-06	0.0002	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—lung cancer	4.21e-06	0.000195	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—B4GALT5—lung cancer	4.07e-06	0.000188	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PLBD1—lung cancer	4.04e-06	0.000187	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ERCC2—lung cancer	3.99e-06	0.000185	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTA4—lung cancer	3.96e-06	0.000183	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.87e-06	0.000179	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTA2—lung cancer	3.86e-06	0.000179	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTA1—lung cancer	3.72e-06	0.000172	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HSD17B10—lung cancer	3.69e-06	0.000171	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCC3—lung cancer	3.68e-06	0.00017	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MYC—lung cancer	3.6e-06	0.000167	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AKR1C1—lung cancer	3.56e-06	0.000165	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—UGT1A1—lung cancer	3.46e-06	0.00016	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CKB—lung cancer	3.43e-06	0.000159	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GNG11—lung cancer	3.34e-06	0.000154	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.32e-06	0.000154	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTM2—lung cancer	3.23e-06	0.00015	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CNDP2—lung cancer	3.23e-06	0.00015	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALDOA—lung cancer	3.18e-06	0.000147	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MTMR3—lung cancer	3.14e-06	0.000145	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NCOA3—lung cancer	3.08e-06	0.000143	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PGAM1—lung cancer	3.06e-06	0.000142	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.03e-06	0.00014	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ADCY1—lung cancer	3e-06	0.000139	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCG2—lung cancer	3e-06	0.000139	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ENO2—lung cancer	2.94e-06	0.000136	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HPGDS—lung cancer	2.94e-06	0.000136	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—CREBBP—lung cancer	2.92e-06	0.000135	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPP2R1B—lung cancer	2.92e-06	0.000135	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP2A7—lung cancer	2.92e-06	0.000135	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.88e-06	0.000134	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SDC4—lung cancer	2.86e-06	0.000132	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTT1—lung cancer	2.85e-06	0.000132	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP2A6—lung cancer	2.82e-06	0.000131	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GCLC—lung cancer	2.82e-06	0.000131	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.81e-06	0.00013	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ENO1—lung cancer	2.67e-06	0.000124	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.66e-06	0.000123	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.63e-06	0.000122	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTA3—lung cancer	2.6e-06	0.000121	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—RRM1—lung cancer	2.6e-06	0.000121	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—B4GALT5—lung cancer	2.45e-06	0.000113	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP2E1—lung cancer	2.4e-06	0.000111	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTA4—lung cancer	2.38e-06	0.00011	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NQO1—lung cancer	2.37e-06	0.00011	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.32e-06	0.000108	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTA2—lung cancer	2.32e-06	0.000107	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.3e-06	0.000107	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTA1—lung cancer	2.24e-06	0.000104	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCC3—lung cancer	2.21e-06	0.000102	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AKR1C1—lung cancer	2.14e-06	9.92e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—STK11—lung cancer	2.14e-06	9.9e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—UGT1A1—lung cancer	2.08e-06	9.63e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.01e-06	9.29e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GNG11—lung cancer	2.01e-06	9.29e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTP1—lung cancer	1.98e-06	9.16e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CAT—lung cancer	1.92e-06	8.91e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.91e-06	8.86e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALDOA—lung cancer	1.91e-06	8.85e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCB1—lung cancer	1.87e-06	8.67e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NCOA3—lung cancer	1.85e-06	8.59e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TYMS—lung cancer	1.84e-06	8.51e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTM1—lung cancer	1.82e-06	8.42e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ADCY1—lung cancer	1.8e-06	8.35e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCG2—lung cancer	1.8e-06	8.35e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MAPK3—lung cancer	1.78e-06	8.26e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ENO2—lung cancer	1.77e-06	8.19e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HPGDS—lung cancer	1.77e-06	8.19e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.76e-06	8.14e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MYC—lung cancer	1.74e-06	8.03e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP1A1—lung cancer	1.72e-06	7.98e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTT1—lung cancer	1.72e-06	7.95e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ERCC2—lung cancer	1.71e-06	7.91e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GCLC—lung cancer	1.7e-06	7.85e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP2A6—lung cancer	1.7e-06	7.85e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ENO1—lung cancer	1.61e-06	7.45e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APOA1—lung cancer	1.48e-06	6.84e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP2E1—lung cancer	1.44e-06	6.68e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NQO1—lung cancer	1.43e-06	6.6e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.42e-06	6.55e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CG—lung cancer	1.35e-06	6.25e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—STK11—lung cancer	1.29e-06	5.95e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—POMC—lung cancer	1.28e-06	5.95e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CREBBP—lung cancer	1.25e-06	5.79e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AKT1—lung cancer	1.2e-06	5.57e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTP1—lung cancer	1.19e-06	5.51e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CD—lung cancer	1.19e-06	5.49e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALB—lung cancer	1.17e-06	5.42e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CAT—lung cancer	1.16e-06	5.36e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCB1—lung cancer	1.13e-06	5.21e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TYMS—lung cancer	1.11e-06	5.12e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTM1—lung cancer	1.09e-06	5.06e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP1A1—lung cancer	1.04e-06	4.8e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CB—lung cancer	1.03e-06	4.79e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ERCC2—lung cancer	1.03e-06	4.76e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS2—lung cancer	1.02e-06	4.74e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTEN—lung cancer	8.94e-07	4.14e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APOA1—lung cancer	8.89e-07	4.12e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—EP300—lung cancer	8.52e-07	3.95e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CG—lung cancer	8.12e-07	3.76e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—POMC—lung cancer	7.73e-07	3.58e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CREBBP—lung cancer	7.53e-07	3.48e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CD—lung cancer	7.13e-07	3.3e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALB—lung cancer	7.04e-07	3.26e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CA—lung cancer	6.3e-07	2.92e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CB—lung cancer	6.22e-07	2.88e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS2—lung cancer	6.16e-07	2.85e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTEN—lung cancer	5.37e-07	2.49e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AKT1—lung cancer	5.15e-07	2.38e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—EP300—lung cancer	5.13e-07	2.37e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CA—lung cancer	3.79e-07	1.76e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AKT1—lung cancer	3.1e-07	1.43e-05	CbGpPWpGaD
